RNA vs Chutes

Chutes (SN64) is 19.4× the size of RNA (SN117) by market capitalisation. Over the past 30 days, SN117 is ahead by 28.3 percentage points (SN117 +21.4% against SN64 -6.9%). Their daily returns move very closely together (correlation 0.92 across 23 shared trading days). Both have run at a similar volatility, around 151% annualised.

Correlation: 0.92
Size ratio: 1 : 19.4
Ahead over 30 days: SN117

RNASN117

$1.7900

24h: -0.56%
Market cap: $5.12M
Volume 24h: $865,917
Volatility (ann.): 161%

ChutesSN64

$15.6800

24h: +3.22%
Market cap: $99.22M
Volume 24h: $472,764
Volatility (ann.): 141%

SN117 4.9%Share of the two combined market caps95.1% SN64

Performance

SN117SN64

7 days-18.52%-11.80%SN64
30 days+21.37%-6.90%SN117

Correlation

0.92over 23 shared trading days

−1 opposite0 unrelated+1 in step

7d: insufficient data30d: insufficient data90d: insufficient data1y: insufficient data

Measured on daily returns rather than on prices. Two assets that both simply trend upward score near 1.0 on raw prices whether or not they move together, so returns are what answer the question people mean by correlation.

Risk & extremes

Metric	SN117	SN64
Max drawdown (400d)	-28.8%	-32.6%
Risk-adjusted return (90d)	0.13	0.00

Relative strength over 90 days: SN117 outperformed SN64 by 5.0% — measured on the SN117/SN64 ratio, so it holds regardless of market direction.

RNA →Chutes →